Trials / Unknown
UnknownNCT04820166
The Effect of Monitoring PVP on Clinical Outcomes in Patients With PH
The Effect of Monitoring Portal Venous Pressure on Clinical Outcomes in Patients With Portal Hypertension: a Prospective, Single-center, Observational Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
The complications associated with portal hypertension in cirrhosis are the main cause of death in patients with cirrhosis. The level of portal venous pressure is closely related to the prognosis of patients. HVPG (hepatic venous pressure gradient) is the "gold standard" for predicting portal venous pressure and an important indicator for evaluating the efficacy of NSBBS. However, monitoring HVPG has many limitations,and the clinical application is also limited to a certain extent. Therefore, this study intends to clarify the guiding value of monitoring portal venous pressure in the clinical diagnosis and treatment of portal hypertension patients through a single-center, prospective and observational study. Therefore, this study intends to clarify the guiding value of monitoring portal venous pressure in the clinical diagnosis and treatment of portal hypertension patients through a single-center, prospective and observational study. At the same time, to explore the correlation between HVPG and PPG in cirrhosis patients at different stages and different etiologies, and to evaluate the role of spleen stiffness in predicting the severity of esophageal and gastric varices in patients with portal hypertension, and to find biomarkers to predict the risk of complications related to portal hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | monitoring portal pressure gradient or hepatic venous pressure gradient | measuring portal pressure gradient or hepatic venous pressure gradient regularly |
Timeline
- Start date
- 2021-03-12
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2021-03-29
- Last updated
- 2021-03-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04820166. Inclusion in this directory is not an endorsement.